2026 Q1 -tulosraportti
84 päivää sitten
‧35 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 28.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·24.7.With an expectation of final approval by the end of 2026, I don't think we should count on revenue in the EU before the latter part of 2027, and one should probably not be surprised if it's not until 2028 that real revenue can be booked. We have seen from Brazil how sluggish the process can be. This means it is still crucial that aXivite delivers strong growth, that we start to see some steady revenue from aXiphen in Brazil, and that aXiphen ruminant also gains some momentum before we see positive cash flow. Q2 has historically been a really strong quarter for aXivite, and if they can grow the numbers from Q2 last year, then it looks good. But there is no guarantee. Having said that, I think there is reason for cautious optimism regarding the long-term case. There are many exciting opportunities, but it requires management to be able to execute on them. I look forward to the next report in August, where we will get the next update. In the meantime, potential triggers will be new customers/orders from Brazil.- ·13.7. · MuokattuSo the minutes are ready: https://www.efsa.europa.eu/sites/default/files/2026-07/feedap260630-0702_m.pdf Phenylcapsaicin as zootechnical additive for chickens for fattening (EFSA-Q-2025- 00428) EFSA was requested to deliver an opinion on the safety and efficacy of phenylcapsaicin as a zootechnical additive for chickens for fattening. MEETING MINUTES – 30 June – 02 July 2026 189th FEEDAP Plenary meeting The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety and efficacy. The Panel unanimously adopted the opinion. So we have the approval! It's not entirely official yet. The decision must be officially published before there is a real permit to sell, as I understand it. That could take a couple of months. But that's a technicality.
- ·23.6.The agenda for FEEDAP Panel Plenary #189 has arrived. Here is good news. Item 6.15 on the agenda is the discussion of phenylcapsaicin. The meeting runs from June 30 to July 2, and the minutes are typically available a couple of days later. If the data aXichem has presented here is good enough, then one should look for something along the lines of: "The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety. The Panel unanimously adopted the opinion." The full agenda can be found here: https://www.efsa.europa.eu/en/events/189th-plenary-meeting-feedap-panel It is also here that the minutes (Minutes) will be made available.
·19.2. · MuokattuNo impressive red figures 2025 and weak uncertain forecast going forward 2026. The price will likely end up a bit below 1 krona, perhaps already this afternoon!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
84 päivää sitten
‧35 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·24.7.With an expectation of final approval by the end of 2026, I don't think we should count on revenue in the EU before the latter part of 2027, and one should probably not be surprised if it's not until 2028 that real revenue can be booked. We have seen from Brazil how sluggish the process can be. This means it is still crucial that aXivite delivers strong growth, that we start to see some steady revenue from aXiphen in Brazil, and that aXiphen ruminant also gains some momentum before we see positive cash flow. Q2 has historically been a really strong quarter for aXivite, and if they can grow the numbers from Q2 last year, then it looks good. But there is no guarantee. Having said that, I think there is reason for cautious optimism regarding the long-term case. There are many exciting opportunities, but it requires management to be able to execute on them. I look forward to the next report in August, where we will get the next update. In the meantime, potential triggers will be new customers/orders from Brazil.
- ·13.7. · MuokattuSo the minutes are ready: https://www.efsa.europa.eu/sites/default/files/2026-07/feedap260630-0702_m.pdf Phenylcapsaicin as zootechnical additive for chickens for fattening (EFSA-Q-2025- 00428) EFSA was requested to deliver an opinion on the safety and efficacy of phenylcapsaicin as a zootechnical additive for chickens for fattening. MEETING MINUTES – 30 June – 02 July 2026 189th FEEDAP Plenary meeting The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety and efficacy. The Panel unanimously adopted the opinion. So we have the approval! It's not entirely official yet. The decision must be officially published before there is a real permit to sell, as I understand it. That could take a couple of months. But that's a technicality.
- ·23.6.The agenda for FEEDAP Panel Plenary #189 has arrived. Here is good news. Item 6.15 on the agenda is the discussion of phenylcapsaicin. The meeting runs from June 30 to July 2, and the minutes are typically available a couple of days later. If the data aXichem has presented here is good enough, then one should look for something along the lines of: "The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety. The Panel unanimously adopted the opinion." The full agenda can be found here: https://www.efsa.europa.eu/en/events/189th-plenary-meeting-feedap-panel It is also here that the minutes (Minutes) will be made available.
- ·19.2. · MuokattuNo impressive red figures 2025 and weak uncertain forecast going forward 2026. The price will likely end up a bit below 1 krona, perhaps already this afternoon!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 28.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
2026 Q1 -tulosraportti
84 päivää sitten
‧35 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 27.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 19.2. | ||
2025 Q3 -tulosraportti 28.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 22.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·24.7.With an expectation of final approval by the end of 2026, I don't think we should count on revenue in the EU before the latter part of 2027, and one should probably not be surprised if it's not until 2028 that real revenue can be booked. We have seen from Brazil how sluggish the process can be. This means it is still crucial that aXivite delivers strong growth, that we start to see some steady revenue from aXiphen in Brazil, and that aXiphen ruminant also gains some momentum before we see positive cash flow. Q2 has historically been a really strong quarter for aXivite, and if they can grow the numbers from Q2 last year, then it looks good. But there is no guarantee. Having said that, I think there is reason for cautious optimism regarding the long-term case. There are many exciting opportunities, but it requires management to be able to execute on them. I look forward to the next report in August, where we will get the next update. In the meantime, potential triggers will be new customers/orders from Brazil.
- ·13.7. · MuokattuSo the minutes are ready: https://www.efsa.europa.eu/sites/default/files/2026-07/feedap260630-0702_m.pdf Phenylcapsaicin as zootechnical additive for chickens for fattening (EFSA-Q-2025- 00428) EFSA was requested to deliver an opinion on the safety and efficacy of phenylcapsaicin as a zootechnical additive for chickens for fattening. MEETING MINUTES – 30 June – 02 July 2026 189th FEEDAP Plenary meeting The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety and efficacy. The Panel unanimously adopted the opinion. So we have the approval! It's not entirely official yet. The decision must be officially published before there is a real permit to sell, as I understand it. That could take a couple of months. But that's a technicality.
- ·23.6.The agenda for FEEDAP Panel Plenary #189 has arrived. Here is good news. Item 6.15 on the agenda is the discussion of phenylcapsaicin. The meeting runs from June 30 to July 2, and the minutes are typically available a couple of days later. If the data aXichem has presented here is good enough, then one should look for something along the lines of: "The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety. The Panel unanimously adopted the opinion." The full agenda can be found here: https://www.efsa.europa.eu/en/events/189th-plenary-meeting-feedap-panel It is also here that the minutes (Minutes) will be made available.
- ·19.2. · MuokattuNo impressive red figures 2025 and weak uncertain forecast going forward 2026. The price will likely end up a bit below 1 krona, perhaps already this afternoon!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt